XNAS:F:F-Xtrackers NASDAQ 100 UCITS ETF 1C EUR (EUR)

ETF | Others |

Last Closing

USD 40.705

Change

-0.60 (-1.44)%

Market Cap

USD 0.67B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.06 (+0.11%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.01 (+0.02%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.65 (+0.27%)

USD 53.24B
VUSA:F Vanguard Funds Public Limited ..

+0.97 (+1.01%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.39 (-0.40%)

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.14 (+0.09%)

USD 37.92B

ETFs Containing XNAS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.35% 82% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.35% 79% B- 65% D
Trailing 12 Months  
Capital Gain 28.49% 85% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.49% 82% B 68% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 16.98% 93% A 81% B-
Dividend Return 16.98% 91% A- 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.39% 30% F 70% C-
Risk Adjusted Return 97.66% 96% N/A 95% A
Market Capitalization 0.67B 65% D 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.